Borer Denton & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.32M Buy
19,248
+4,899
+34% +$566K 0.83% 32
2025
Q4
$1.51M Sell
14,349
-275
-2% -$25.8K 0.51% 34
2025
Q3
$1.23M Sell
14,624
-1,000
-6% -$82.4K 0.41% 38
2025
Q2
$1.24M Sell
15,624
-100
-0.6% -$7.95K 0.43% 37
2025
Q1
$1.41M Sell
15,724
-400
-2% -$37.3K 0.5% 36
2024
Q4
$1.6M Buy
16,124
+511
+3% +$52.7K 0.56% 34
2024
Q3
$1.77M Hold
15,613
0.6% 33
2024
Q2
$1.93M Hold
15,613
0.7% 31
2024
Q1
$2.06M Sell
15,613
-755
-5% -$93.1K 0.73% 31
2023
Q4
$1.78M Hold
16,368
0.68% 31
2023
Q3
$1.69M Buy
16,368
+136
+0.8% +$14.7K 0.7% 31
2023
Q2
$1.87M Hold
16,232
0.74% 30
2023
Q1
$1.73M Buy
16,232
+874
+6% +$94.4K 0.72% 32
2022
Q4
$1.7M Buy
15,358
+472
+3% +$48.2K 0.75% 30
2022
Q3
$1.28M Buy
14,886
+1,875
+14% +$167K 0.64% 32
2022
Q2
$1.19M Sell
13,011
-4,675
-26% -$414K 0.57% 34
2022
Q1
$1.45M Buy
+17,686
New +$1.39M 0.61% 32

Other funds holding MRK

Borer Denton & Associates's MRK Position: Q1 2026 in Review

Borer Denton & Associates increased its Merck (MRK) stake by 34% in Q1 2026, buying an estimated $566K and bringing the position to 19,248 shares worth $2.32M. The position accounts for 0.83% of the portfolio, ranked #32.

Borer Denton & Associates first reported a position in MRK in Q1 2022 and has held it in 17 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Borer Denton & Associates held 19,248 shares of Merck worth $2.32M as of Q1 2026.
  • Borer Denton & Associates bought 4,899 Merck shares in Q1 2026, an estimated $566K.
  • Merck made up 0.83% of Borer Denton & Associates's portfolio in Q1 2026, its #32 holding.
  • Borer Denton & Associates first reported a position in Merck in Q1 2022 and has held it in 17 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Borer Denton & Associates's 13F filing for Q1 2026, filed 12 May 2026.